Synthetic engineered bacteria for cancer therapy

References

• Bhatt AP, Redinbo MR, Bultman SJ. The Role of the Microbiome in Cancer Development and Therapy. CA Cancer J Clin. 2017;67(4):326–344. doi: 10.3322/caac.21398
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. Ca A Cancer J Clinicians. 2022;72(1):7–33. doi: 10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• André N, Carré M, Pasquier E. Metronomics: towards personalized chemotherapy? Nat Rev Clin Oncol. 2014;11(7):413–431. doi: 10.1038/nrclinonc.2014.89
   PubMed Web of Science ®Google Scholar
• Schaue D, McBride WH. Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015;12(9):527–540. doi: 10.1038/nrclinonc.2015.120
   PubMed Web of Science ®Google Scholar
• Citrin DE, Longo DL. Recent Developments in Radiotherapy. N Engl J Med. 2017;377(11):1065–1075. doi: 10.1056/NEJMra1608986
   PubMed Web of Science ®Google Scholar
• Petroni G, Cantley LC, Santambrogio L, et al. Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer. Nat Rev Clin Oncol. 2022;19(2):114–131. doi: 10.1038/s41571-021-00579-w
   PubMed Web of Science ®Google Scholar
• Chabner BA, Roberts TG. Chemotherapy and the war on cancer. Nat Rev Cancer. 2005;5(1):65–72. doi: 10.1038/nrc1529
   PubMed Web of Science ®Google Scholar
• Behranvand N, Nasri F, Zolfaghari Emameh R, et al. Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunol Immunother. 2022;71(3):507–526. doi: 10.1007/s00262-021-03013-3
   PubMed Web of Science ®Google Scholar
• Davis AJ, Tannock IF. Tumor physiology and resistance to chemotherapy: repopulation and drug penetration. Cancer Treat Res. 2002;112:1–26.
   PubMedGoogle Scholar
• Bashor CJ, Hilton IB, Bandukwala H, et al. Engineering the next generation of cell-based therapeutics. Nat Rev Drug Discov. 2022;21(9):655–675. doi: 10.1038/s41573-022-00476-6
   PubMed Web of Science ®Google Scholar
• Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma. Nature Medicine [Internet]. 2022 Sep [cited 2022 Nov 30];28(9):1848–59. https://www.nature.com/articles/s41591-022-01959-0
   PubMed Web of Science ®Google Scholar
• Next-Generation CAR T-cell Therapies | Cancer Discovery | American Association for Cancer Research [Internet]. [cited 2022 Nov 30]. Available from: https://aacrjournals.org/cancerdiscovery/article-abstract/12/7/1625/705228/Next-Generation-CAR-T-cell-Therapies?redirectedFrom=fulltext
   Google Scholar
• Amini L, Silbert SK, Maude SL, et al. Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion. Nat Rev Clin Oncol. 2022;19(5):342–355. doi: 10.1038/s41571-022-00607-3
   PubMed Web of Science ®Google Scholar
• Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 2021;11(4):1–11. doi: 10.1038/s41408-021-00459-7
   PubMed Web of Science ®Google Scholar
• Outlook for New CAR-Based Therapies with a Focus on CAR NK Cells: What Lies Beyond CAR-Engineered T Cells in the Race against Cancer | Cancer Discovery | American Association for Cancer Research [Internet]. [cited 2022 Nov 30]. Available from: https://aacrjournals.org/cancerdiscovery/article/11/1/45/2895/Outlook-for-New-CAR-Based-Therapies-with-a-Focus
   Google Scholar
• Laskowski TJ, Biederstädt A, Rezvani K. Natural killer cells in antitumour adoptive cell immunotherapy. Nat Rev Cancer. 2022;22(10):557–575. doi: 10.1038/s41568-022-00491-0
   PubMed Web of Science ®Google Scholar
• Baghery Saghchy Khorasani A, Yousefi A-M, Bashash D. CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges. Int Immunopharmacol. 2022;110:109041. doi: 10.1016/j.intimp.2022.109041
   PubMed Web of Science ®Google Scholar
• Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy. Nat Med [Internet]. 2022 Sep [cited 2022 Nov 30];28(9):1860–71. https://www.nature.com/articles/s41591-022-01960-7
   PubMed Web of Science ®Google Scholar
• Fritsche E, Volk H-D, Reinke P, et al. Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy. Trends Biotechnol. 2020;38(10):1099–1112. doi: 10.1016/j.tibtech.2019.12.009
   PubMed Web of Science ®Google Scholar
• Oh S, O’Connor K, Payne A. MuSK Chimeric Autoantibody Receptor (CAAR) T Cells for Antigen-specific Cellular Immunotherapy of Myasthenia Gravis (2769). Neurology. 2020 [cited 2022 Nov 30].;94(15 Supplement). Available from. https://n.neurology.org/content/94/15_Supplement/2769
   Web of Science ®Google Scholar
• Raffin C, Vo LT, Bluestone JA. Treg cell-based therapies: challenges and perspectives. Nat Rev Immunol. 2020;20(3):158–172. doi: 10.1038/s41577-019-0232-6
   PubMed Web of Science ®Google Scholar
• Ando M, Kinoshita S, Furukawa Y. Chapter 3 - Improving the safety of Ipsc-derived T cell therapy. In: Birbrair A, Eds. Molecular Players in iPSC Technology. Academic Press; 2022. p. 95–115. 10.1016/B978-0-323-90059-1.00010-5.
   Google Scholar
• Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial. Natu Med [Internet]. 2021 Aug [cited 2022 Nov 30];27(8):1410–8. https://www.nature.com/articles/s41591-021-01462-y
   PubMed Web of Science ®Google Scholar
• Zhao Y, Deng J, Rao S, et al. Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges. Cancers. 2022;14(17):4160. doi: 10.3390/cancers14174160
   PubMed Web of Science ®Google Scholar
• Rakaee M, Adib E, Ricciuti B, et al. Association of Machine Learning–Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images with Outcomes of Immunotherapy in Patients with NSCLC. JAMA Oncol. 2022;9:51. doi: 10.1001/jamaoncol.2022.4933
   Google Scholar
• Rosenberg SA, Packard BS, Aebersold PM, et al. Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma. 2010;Internet. doi: 10.1056/NEJM198812223192527
   Google Scholar
• Rosenberg SA, Yannelli JR, Yang JC, et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst. 1994;86(15):1159–1166. doi: 10.1093/jnci/86.15.1159
   PubMed Web of Science ®Google Scholar
• Irvine DJ, Maus MV, Mooney DJ, et al. The future of engineered immune cell therapies. Science. 2022;378(6622):853–858. doi: 10.1126/science.abq6990
   PubMed Web of Science ®Google Scholar
• Weber EW, Maus MV, Mackall CL. The Emerging Landscape of Immune Cell Therapies. Cell. 2020;181(1):46–62. doi: 10.1016/j.cell.2020.03.001
   PubMed Web of Science ®Google Scholar
• Mount CW, Majzner RG, Sundaresh S, et al. Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas. Nat Med. 2018;24(5):572–579. doi: 10.1038/s41591-018-0006-x
   PubMed Web of Science ®Google Scholar
• Halliwell E, Vitali A, Muller H, et al. Targeting of low ALK antigen density neuroblastoma using and logic-gate engineered CAR-T cells. Cytotherapy. 2022;25:46–58. doi: 10.1016/j.jcyt.2022.10.007
   PubMed Web of Science ®Google Scholar
• Hou AJ, Chen LC, Chen YY. Navigating CAR-T cells through the solid-tumour microenvironment. Nat Rev Drug Discov. 2021;20(7):531–550. doi: 10.1038/s41573-021-00189-2
   PubMed Web of Science ®Google Scholar
• Vitanza NA, Wilson AL, Huang W, et al. Intraventricular B7-H3 CAR T cells for diffuse intrinsic pontine glioma: preliminary first-in-human bioactivity and safety. Cancer Discovery. 2023;13(1) :141–131.
   Web of Science ®Google Scholar
• Nagarsheth NB, Norberg SM, Sinkoe AL, et al. TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat Med. 2021;27(3):419–425. doi: 10.1038/s41591-020-01225-1
   PubMed Web of Science ®Google Scholar
• Tzannou I, Papadopoulou A, Naik S, et al. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. JCO. 2017;35(31):3547–3557. doi: 10.1200/JCO.2017.73.0655
   PubMed Web of Science ®Google Scholar
• McLaughlin LP, Rouce R, Gottschalk S, et al. EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation. Blood. 2018;132(22):2351–2361. doi: 10.1182/blood-2018-07-863654
   PubMed Web of Science ®Google Scholar
• Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients - ScienceDirect [Internet]. [cited 2022 Nov 30]. Available from: https://www.sciencedirect.com/science/article/pii/S1525001617305282
   Google Scholar
• CXCR5-Dependent Entry of CD8 T Cells into Rhesus Macaque B-Cell Follicles Achieved through T-Cell Engineering. J Virol. [cited 2022 Nov 30]. Internet. https://journals.asm.org/doi/full/10.1128/JVI.02507-16
   Web of Science ®Google Scholar
• Larson SM, Walthers CM, Ji B, et al. CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma. Cancer Discovery. 2023;13(3) :580–597.
   PubMedGoogle Scholar
• Fry TJ, Shah NN, Orentas RJ, et al. CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy. Nat Med. 2018;24(1):20–28. doi: 10.1038/nm.4441
   PubMed Web of Science ®Google Scholar
• Van Oekelen O, Aleman A, Upadhyaya B, et al. Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy. Nat Med. 2021;27(12):2099–2103. doi: 10.1038/s41591-021-01564-7
   PubMed Web of Science ®Google Scholar
• Anderson KG, Stromnes IM, Greenberg PD. Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies. Cancer Cell. 2017;31(3):311–325. doi: 10.1016/j.ccell.2017.02.008
   PubMed Web of Science ®Google Scholar
• Guppy M. The hypoxic core: a possible answer to the cancer paradox. Biochem Biophys Res Commun. 2002;299(4):676–680. doi: 10.1016/S0006-291X(02)02710-9
   PubMed Web of Science ®Google Scholar
• The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell International Internet. 2021 Dec;21(1):1–26. [cited 2022 Nov 30]. https://cancerci.biomedcentral.com/articles/10.1186/s12935-020-01719-5
   Google Scholar
• Zhou S, Gravekamp C, Bermudes D, et al. Tumour-targeting bacteria engineered to fight cancer. Nat Rev Cancer. 2018;18(12):727–743. doi: 10.1038/s41568-018-0070-z
   PubMed Web of Science ®Google Scholar
• Engineering the perfect (bacterial) cancer therapy. Natu Reviews Cancer. 2010 Nov [Internet]. [cited 2022 Nov 29];10(11):785–94. https://www.nature.com/articles/nrc2934
   PubMed Web of Science ®Google Scholar
• Jiang S-N, Phan TX, Nam T-K, et al. Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy. Mol Ther. 2010;18(3):635–642. doi: 10.1038/mt.2009.295
   PubMed Web of Science ®Google Scholar
• Gurbatri CR, Arpaia N, Danino T. Engineering bacteria as interactive cancer therapies. Science. 2022;378(6622):858–864. doi: 10.1126/science.add9667
   PubMed Web of Science ®Google Scholar
• Duong M-Q, Qin Y, You S-H, et al. Bacteria-cancer interactions: bacteria-based cancer therapy. Exp Mol Med. 2019;51(12):152. doi: 10.1038/s12276-019-0297-0
   PubMedGoogle Scholar
• Felgner S, Pawar V, Kocijancic D, et al. Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome. Microbiol Biotechnol. 2017;10(5):1074–1078. doi: 10.1111/1751-7915.12787
   Google Scholar
• Multiplexed biosensors for precision bacteria tropism in vivo | bioRxiv Internet. [cited 2022 Nov 30]. Available from. https://www.biorxiv.org/content/10.1101/851311v1
   Google Scholar
• Clairmont C, Lee KC, Pike J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis. 2000;181(6):1996–2002. doi: 10.1086/315497
   PubMed Web of Science ®Google Scholar
• Park S-H, Zheng JH, Nguyen VH, et al. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy. Theranostics. 2016;6(10):1672–1682. doi: 10.7150/thno.16135
   PubMed Web of Science ®Google Scholar
• Massa PE, Paniccia A, Monegal A, et al. Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. Blood. 2013;122(5):705–714. doi: 10.1182/blood-2012-12-474098
   PubMed Web of Science ®Google Scholar
• Riglar DT, Silver PA. Engineering bacteria for diagnostic and therapeutic applications. Nat Rev Microbiol. 2018;16(4):214–225. doi: 10.1038/nrmicro.2017.172
   PubMed Web of Science ®Google Scholar
• Dang LH, Bettegowda C, Huso DL, et al. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci, USA. 2001;98(26):15155–15160. doi: 10.1073/pnas.251543698
   PubMed Web of Science ®Google Scholar
• Gupta KH, Nowicki C, Giurini EF, et al. Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy. Vaccines (Basel). 2021;9(12):1497. doi: 10.3390/vaccines9121497
   PubMed Web of Science ®Google Scholar
• Wang W, Xu H, Ye Q, et al. Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria. Nat Biomed Eng. 2022;6(1):44–53. doi: 10.1038/s41551-021-00834-6
   PubMed Web of Science ®Google Scholar
• Du Y, Lin L, Zhang Z, et al. Drug-loaded nanoparticles conjugated with genetically engineered bacteria for cancer therapy. Biochem Biophys Res Commun. 2022;606:29–34. doi: 10.1016/j.bbrc.2022.03.049
   PubMed Web of Science ®Google Scholar
• Hu Q, Wu M, Fang C, et al. Engineering Nanoparticle-Coated Bacteria as Oral DNA Vaccines for Cancer Immunotherapy. Nano Lett. 2015;15(4):2732–2739. doi: 10.1021/acs.nanolett.5b00570
   PubMed Web of Science ®Google Scholar
• Feng J, Liu Y, Pan X, et al. Acid-Directed Electrostatic Self-Assembly Generates Charge-Reversible Bacteria for Enhanced Tumor Targeting and Low Tissue Trapping. ACS Appl Mater Interfaces. 2022;14(32):36411–36424. doi: 10.1021/acsami.2c08684
   PubMed Web of Science ®Google Scholar
• Chen Q, Li Q, Cao M, et al. Hierarchy‐Assembled Dual Probiotics System Ameliorates Cholestatic Drug‐Induced Liver Injury via Gut‐Liver Axis Modulation. Adv Sci. 2022;9(17):2200986. doi: 10.1002/advs.202200986
   Web of Science ®Google Scholar
• Anselmo AC, McHugh KJ, Webster J, et al. Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome. Adv Mater. 2016;28(43):9486–9490. doi: 10.1002/adma.201603270
   PubMed Web of Science ®Google Scholar
• Zhu D, Zhang J, Luo G, et al. Bright Bacterium for Hypoxia‐Tolerant Photodynamic Therapy Against Orthotopic Colon Tumors by an Interventional Method. Adv Sci. 2021;8(15):2004769. doi: 10.1002/advs.202004769
   Web of Science ®Google Scholar
• Wei B, Pan J, Yuan R, et al. Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy. Nano Lett. 2021;21(10):4231–4240. doi: 10.1021/acs.nanolett.1c00209
   PubMed Web of Science ®Google Scholar
• Tian Q, Bagheri Y, Keshri P, et al. Efficient and selective DNA modification on bacterial membranes. Chem Sci. 2021;12(7):2629–2634. doi: 10.1039/D0SC06630C
   Web of Science ®Google Scholar
• Zhao W-B, Wang R-T, Liu K-K, et al. Near-infrared carbon nanodots for effective identification and inactivation of Gram-positive bacteria. Nano Res. 2022;15(3):1699–1708. doi: 10.1007/s12274-021-3818-9
   Web of Science ®Google Scholar
• Jia H-R, Zhu Y-X, Chen Z, et al. Cholesterol-Assisted Bacterial Cell Surface Engineering for Photodynamic Inactivation of Gram-Positive and Gram-Negative Bacteria. ACS Appl Mater Interfaces. 2017;9(19):15943–15951. doi: 10.1021/acsami.7b02562
   PubMed Web of Science ®Google Scholar
• Yang X, Yang J, Ye Z, et al. Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization. ACS Nano. 2022;16(3):4041–4058. doi: 10.1021/acsnano.1c09681
   PubMed Web of Science ®Google Scholar
• Liu R, Cao Z, Wang L, et al. Multimodal oncolytic bacteria by coating with tumor cell derived nanoshells. Nano Today. 2022;45:101537. doi: 10.1016/j.nantod.2022.101537
   Web of Science ®Google Scholar
• Yang J, Zhang G, Yang X, et al. An oral “Super probiotics” with versatile self-assembly adventitia for enhanced intestinal colonization by autonomous regulating the pathological microenvironment. Chem Eng J. 2022;446:137204. doi: 10.1016/j.cej.2022.137204
   Web of Science ®Google Scholar
• Liu Y, Lu Y, Ning B, et al. Intravenous Delivery of Living Listeria monocytogenes Elicits Gasdmermin-Dependent Tumor Pyroptosis and Motivates Anti-Tumor Immune Response. ACS Nano. 2022;16(3):4102–4115. doi: 10.1021/acsnano.1c09818
   PubMed Web of Science ®Google Scholar
• Encapsulation of Commensal Skin Bacteria within Membrane‐in‐Gel Patches - Xu - 2022 - Advanced Materials Interfaces - Wiley Online Library Internet. [cited 2022 Nov 26]. Available from. https://onlinelibrary.wiley.com/doi/10.1002/admi.202102261
   Google Scholar
• Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches [Internet]. doi: 10.1126/sciadv.abf0677
   Google Scholar
• Cao Z, Cheng S, Wang X, et al. Camouflaging bacteria by wrapping with cell membranes. Nat Commun. 2019;10(1):3452. doi: 10.1038/s41467-019-11390-8
   PubMed Web of Science ®Google Scholar
• Bioinspired oral delivery of gut microbiota by self-coating with biofilms [Internet]. DOI: 10.1126/sciadv.abb1952
   Google Scholar
• Garcés V, González A, Gálvez N, et al. Magneto-optical hyperthermia agents based on probiotic bacteria loaded with magnetic and gold nanoparticles. Nanoscale. 2022;14(15):5716–5724. doi: 10.1039/D1NR08513A
   PubMed Web of Science ®Google Scholar
• Aubry M, Wang W-A, Guyodo Y, et al. Engineering E. coli for Magnetic Control and the Spatial Localization of Functions. ACS Synth Biol. 2020;9(11):3030–3041. doi: 10.1021/acssynbio.0c00286
   PubMed Web of Science ®Google Scholar
• Garcés V, Rodríguez-Nogales A, González A, et al. Bacteria-Carried Iron Oxide Nanoparticles for Treatment of Anemia. Bioconjugate Chem. 2018;29(5):1785–1791. doi: 10.1021/acs.bioconjchem.8b00245
   PubMed Web of Science ®Google Scholar
• Wang P, Chen C, Wang Q, et al. Tumor inhibition via magneto-mechanical oscillation by magnetotactic bacteria under a swing MF. J Control Release. 2022;351:941–953. doi: 10.1016/j.jconrel.2022.09.059
   PubMed Web of Science ®Google Scholar
• Chen C, Wang P, Chen H, et al. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field. ACS Appl Mater Interfaces. 2022;14(12):14049–14058. doi: 10.1021/acsami.1c24154
   PubMed Web of Science ®Google Scholar
• Wilson WW, Wade MM, Holman SC, et al. Status of methods for assessing bacterial cell surface charge properties based on zeta potential measurements. J Microbiol Methods. 2001;43(3):153–164. doi: 10.1016/S0167-7012(00)00224-4
   PubMed Web of Science ®Google Scholar
• Beveridge TJ, Graham LL. Surface layers of bacteria. Microbiol Rev. 1991;55(4):684–705. doi: 10.1128/mr.55.4.684-705.1991
   PubMedGoogle Scholar
• Gao Z, Zhang E, Zhao H, et al. Bacteria-Mediated Intracellular Click Reaction for Drug Enrichment and Selective Apoptosis of Drug-Resistant Tumor Cells. ACS Appl Mater Interfaces. 2022;14(10):12106–12115. doi: 10.1021/acsami.2c01493
   PubMed Web of Science ®Google Scholar
• Kapoor N, Uchiyama S, Pill L, et al. Non-Native Amino Acid Click Chemistry-Based Technology for Site-Specific Polysaccharide Conjugation to a Bacterial Protein Serving as Both Carrier and Vaccine Antigen. ACS Omega. 2022;7(28):24111–24120. doi: 10.1021/acsomega.1c07360
   PubMed Web of Science ®Google Scholar
• Welling MM, Duszenko N, van Willigen DM, et al. Interventional nuclear medicine: “click” chemistry as an in vivo targeting strategy for imaging microspheres and bacteria. Biomater Sci. 2021;9(5):1683–1690. doi: 10.1039/D0BM01823F
   PubMed Web of Science ®Google Scholar
• Dumont A, Malleron A, Awwad M, et al. Click-Mediated Labeling of Bacterial Membranes through Metabolic Modification of the Lipopolysaccharide Inner Core. Angewandte Chemie. 2012;51(13):3143–3146. doi: 10.1002/anie.201108127
   Google Scholar
• Song W-F, Yao W-Q, Chen Q-W, et al. In Situ Bioorthogonal Conjugation of Delivered Bacteria with Gut Inhabitants for Enhancing Probiotics Colonization. ACS Cent Sci. 2022;8(9):1306–1317. doi: 10.1021/acscentsci.2c00533
   PubMed Web of Science ®Google Scholar
• Fan X-M, Shen J-J, Xu Y-Y, et al. Metabolic integration of azide functionalized glycan on Escherichia coli cell surface for specific covalent immobilization onto magnetic nanoparticles with click chemistry. Biores Technol. 2021;324:124689. doi: 10.1016/j.biortech.2021.124689
   PubMed Web of Science ®Google Scholar
• Pan P, Dong X, Chen Y, et al. Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma. ACS Nano. 2022;16(1):801–812. doi: 10.1021/acsnano.1c08350
   PubMed Web of Science ®Google Scholar
• Pei P, Zhang Y, Jiang Y, et al. Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy. ACS Nano. 2022;16(7):11325–11337. doi: 10.1021/acsnano.2c04982
   PubMed Web of Science ®Google Scholar
• Reghu S, Miyako E. Nanoengineered Bifidobacterium bifidum with Optical Activity for Photothermal Cancer Immunotheranostics. Nano Lett. 2022;22(5):1880–1888. doi: 10.1021/acs.nanolett.1c04037
   PubMed Web of Science ®Google Scholar
• Li J, Xia Q, Guo H, et al. Decorating Bacteria with Triple Immune Nanoactivators Generates Tumor-Resident Living Immunotherapeutics. Angewandte Chemie. 2022;61(27):e202202409. doi: 10.1002/anie.202202409
   Google Scholar
• Xiao S, Shi H, Zhang Y, et al. Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer. J Nanobiotechnology. 2022;20(1):178. doi: 10.1186/s12951-022-01373-1
   PubMed Web of Science ®Google Scholar
• Chen W, Wang Y, Qin M, et al. Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy. ACS Nano. 2018;12(6):5995–6005. doi: 10.1021/acsnano.8b02235
   PubMed Web of Science ®Google Scholar
• Li Y, Tang S, Cong Z, et al. Biohybrid bacterial microswimmers with metal-organic framework exoskeletons enable cytoprotection and active drug delivery in a harsh environment. Mater Today Chem. 2022;23:100609. doi: 10.1016/j.mtchem.2021.100609
   Web of Science ®Google Scholar
• Chen Q-W, Wang J-W, Wang X-N, et al. Inhibition of Tumor Progression through the Coupling of Bacterial Respiration with Tumor Metabolism. Angewandte Chemie. 2020;59(48):21562–21570. doi: 10.1002/anie.202002649
   Google Scholar
• Wang X-N, Niu M-T, Fan J-X, et al. Photoelectric Bacteria Enhance the In Situ Production of Tetrodotoxin for Antitumor Therapy. Nano Lett. 2021;21(10):4270–4279. doi: 10.1021/acs.nanolett.1c00408
   PubMed Web of Science ®Google Scholar
• Wang L, Qin W, Xu W, et al. Bacteria-Mediated Tumor Therapy via Photothermally-Programmed Cytolysin a Expression. Small. 2021;17(40):2102932. doi: 10.1002/smll.202102932
   Web of Science ®Google Scholar
• Wang J-W, Chen Q-W, Luo G-F, et al. A self-driven bioreactor based on bacterium–metal–organic framework biohybrids for boosting chemotherapy via Cyclic Lactate Catabolism. ACS Nano. 2021;15(11):17870–17884. doi: 10.1021/acsnano.1c06123
   PubMed Web of Science ®Google Scholar
• Wasuwanich P, Fan G, Burke B, et al. Metal-phenolic networks as tuneable spore coat mimetics. J Mater Chem B. 2022;10(37):7600–7606. doi: 10.1039/D2TB00717G
   PubMed Web of Science ®Google Scholar
• Pan J, Gong G, Wang Q, et al. A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea. Nat Commun. 2022;13(1):2117. doi: 10.1038/s41467-022-29672-z
   PubMed Web of Science ®Google Scholar
• Centurion F, Merhebi S, Baharfar M, et al. Cell-mediated biointerfacial phenolic assembly for probiotic nano encapsulation. Adv Funct Mater. 2022;32(26):2200775. doi: 10.1002/adfm.202200775
   Web of Science ®Google Scholar
• Wang X, Zhang J, Li K, et al. Photocatalyst-mineralized biofilms as living bio-abiotic interfaces for single enzyme to whole-cell photocatalytic applications. Sci Adv. 2022;8(18):eabm7665. doi: 10.1126/sciadv.abm7665
   PubMed Web of Science ®Google Scholar
• Yao Y, Li J, Li P, et al. Bacterially synthesized tellurium nanorods for elimination of advanced malignant tumor by photothermal immunotherapy. Small. 2022;18(8):2105716. doi: 10.1002/smll.202105716
   Web of Science ®Google Scholar
• Yan S, Zeng X, Wang Y, et al. Biomineralization of bacteria by a metal–organic framework for therapeutic delivery. Adv Healthcare Mater. 2020;9(12):2000046. doi: 10.1002/adhm.202000046
   Web of Science ®Google Scholar
• Li J, Hou W, Lin S, et al. Polydopamine nanoparticle‐mediated dopaminergic immunoregulation in colitis. Adv Sci. 2021;9(1):2104006. doi: 10.1002/advs.202104006
   Web of Science ®Google Scholar
• Liu J, Wang Y, Heelan WJ, et al. Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases. Sci Adv. 2022;8(45):eabp8798. doi: 10.1126/sciadv.abp8798
   PubMed Web of Science ®Google Scholar
• Chen W, He C, Qiao N, et al. Dual drugs decorated bacteria irradiate deep hypoxic tumor and arouse strong immune responses. Biomaterials. 2022;286:121582. doi: 10.1016/j.biomaterials.2022.121582
   PubMed Web of Science ®Google Scholar
• Magnetically steerable bacterial microrobots moving in 3D biological matrices for stimuli-responsive cargo delivery [Internet] DOI: 10.1126/sciadv.abo6163
   Google Scholar
• Alapan Y, Yasa O, Schauer O, et al. Soft erythrocyte-based bacterial microswimmers for cargo delivery. Sci Rob. 2018;3(17):eaar4423. doi: 10.1126/scirobotics.aar4423
   PubMed Web of Science ®Google Scholar
• Chen F, Zang Z, Chen Z, et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials. 2019;214:119226. doi: 10.1016/j.biomaterials.2019.119226
   PubMed Web of Science ®Google Scholar
• Bian J, Bao L, Gao X, et al. Bacteria-engineered porous sponge for hemostasis and vascularization. J Nanobiotechnology. 2022;20(1):47. doi: 10.1186/s12951-022-01254-7
   PubMed Web of Science ®Google Scholar
• Liu L, He H, Luo Z, et al. In Situ photocatalyzed oxygen generation with photosynthetic bacteria to enable robust immunogenic photodynamic therapy in triple‐negative breast cancer. Adv Funct Mater. 2020;30(10):1910176. doi: 10.1002/adfm.201910176
   Web of Science ®Google Scholar
• Fan J, Peng M, Wang H, et al. Engineered bacterial bioreactor for tumor therapy via Fenton‐like reaction with localized H 2 O 2 generation. Adv Mater. 2019;31(16):1808278. doi: 10.1002/adma.201808278
   Web of Science ®Google Scholar
• Suh S, Jo A, Traore MA, et al. Nanoscale Bacteria‐Enabled Autonomous Drug Delivery System (NanoBEADS) Enhances Intratumoral Transport of Nanomedicine. Adv Sci. 2018;6(3):1801309. doi: 10.1002/advs.201801309
   Web of Science ®Google Scholar
• Wu W, Pu Y, Yao H, et al. Microbiotic nanomedicine for tumor-specific chemotherapy-synergized innate/adaptive antitumor immunity. Nano Today. 2022;42:101377. doi: 10.1016/j.nantod.2022.101377
   Web of Science ®Google Scholar
• Gwisai T, Mirkhani N, Christiansen M, et al. Magnetic torque-driven living microrobots for enhanced tumor infiltration; 2022. doi: 10.1101/2022.01.03.473989
   Google Scholar
• Li Z, Mo F, Wang Y, et al. Enhancing Gasdermin-induced tumor pyroptosis through preventing ESCRT-dependent cell membrane repair augments antitumor immune response. Nat Commun. 2022;13(1):6321. doi: 10.1038/s41467-022-34036-8
   PubMed Web of Science ®Google Scholar
• Click Chemistry for Drug Development and Diverse Chemical–Biology Applications. Chem Reviews [Internet]. 2013 Jul 10 [cited 2023 Jan 1];113(7):4905–79. https://pubs.acs.org/doi/10.1021/cr200409f
   PubMed Web of Science ®Google Scholar
• Grzybowski BA, Wilmer CE, Kim J, et al. Self-assembly: from crystals to cells. Soft Matter. 2009;5(6):1110–1128. doi: 10.1039/b819321p
   Web of Science ®Google Scholar
• Grzelczak M, Vermant J, Furst EM, et al. Directed Self-Assembly of Nanoparticles. ACS Nano. 2010;4(7):3591–3605. doi: 10.1021/nn100869j
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang M, Wang X, et al. Dressing bacteria with a hybrid immunoactive nanosurface to elicit dual anticancer and antiviral immunity. Adv Mater 2023;35(11) :2210949.
   Web of Science ®Google Scholar
• Shi L, Liu X, Li Y, et al. Living bacteria-based immuno-photodynamic therapy: metabolic labeling of clostridium butyricum for eradicating malignant melanoma. Adv Sci. 2022;9(14):2105807. doi: 10.1002/advs.202105807
   Web of Science ®Google Scholar
• Pan P, Fan J, Wang X, et al. Bio‐orthogonal bacterial reactor for remission of heavy metal poisoning and ROS Elimination. Adv Sci. 2019;6(24):1902500. doi: 10.1002/advs.201902500
   Web of Science ®Google Scholar
• Geva-Zatorsky N, Alvarez D, Hudak JE, et al. In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat Med. 2015;21(9):1091–1100. doi: 10.1038/nm.3929
   PubMed Web of Science ®Google Scholar
• Hudak JE, Alvarez D, Skelly A, et al. Illuminating vital surface molecules of symbionts in health and disease. Nat Microbiol. 2017;2(9):17099. doi: 10.1038/nmicrobiol.2017.99
   PubMed Web of Science ®Google Scholar
• Wang W, Yang Q, Du Y, et al. Metabolic labeling of peptidoglycan with NIR-II dye enables in vivo imaging of gut microbiota. Angew Chem Int Ed Engl. 2020;59(7):2628–2633. doi: 10.1002/anie.201910555
   PubMed Web of Science ®Google Scholar
• Hu F, Qi G, Null K, et al. Visualization and in situ ablation of intracellular bacterial pathogens through metabolic labeling. Angew Chem Int Ed Engl. 2020;59(24):9288–9292. doi: 10.1002/anie.201910187
   PubMed Web of Science ®Google Scholar
• Liu X, Wu M, Wang M, et al. Metabolically engineered bacteria as light-controlled living therapeutics for anti-angiogenesis tumor therapy. Mater Horiz. 2021;8(5):1454–1460. doi: 10.1039/D0MH01582B
   PubMed Web of Science ®Google Scholar
• Liu X, Wu M, Wang M, et al. Direct synthesis of photosensitizable bacterial cellulose as engineered living material for skin wound repair. Adv Mater. 2022;34(13):2109010. doi: 10.1002/adma.202109010
   Web of Science ®Google Scholar
• Hong S, Zheng D-W, Zhang Q-L, et al. An RGB-emitting molecular cocktail for the detection of bacterial fingerprints. Chem Sci. 2020;11(17):4403–4409. doi: 10.1039/D0SC01704C
   PubMed Web of Science ®Google Scholar
• Beauchemin ET, Hunter C, Maurice CF. Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting. Microbiology. 2022. doi: 10.1101/2022.07.20.500840
   PubMedGoogle Scholar
• Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy. Nat Commun. 2022 Sep 1 [[cited 2022 Dec 30];13(1):5127. Internet: https://www.nature.com/articles/s41467-022-32837-5
   PubMed Web of Science ®Google Scholar
• Canale FP, Basso C, Antonini G, et al. Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature. 2021;598(7882):662–666. doi: 10.1038/s41586-021-04003-2
   PubMed Web of Science ®Google Scholar
• Kurtz CB, Millet YA, Puurunen MK, et al. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med. 2019;11(475):eaau7975. doi: 10.1126/scitranslmed.aau7975
   PubMed Web of Science ®Google Scholar
• Yue Y, Xu J, Li Y, et al. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria. Nat Biomed Eng. 2022;6(7):898–909. doi: 10.1038/s41551-022-00886-2
   PubMed Web of Science ®Google Scholar
• Enhanced Stability and Function of Probiotic Streptococcus thermophilus with Self-Encapsulation by Increasing the Biosynthesis of Hyaluronan. ACS Appl Mater Interfaces. 2022 Sep 16 [cited 2022 Dec 30];14(38):42963–75. https://pubs.acs.org/doi/pdf/10.1021/acsami.2c11591
   PubMedGoogle Scholar
• Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy. Nat Commun [Internet]. 2022 Aug 2 [cited 2022 Dec 30];13(1):4468. https://www.nature.com/articles/s41467-022-31932-x
   PubMed Web of Science ®Google Scholar
• Zhou J, Li M, Chen Q, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13(1):3432. doi: 10.1038/s41467-022-31171-0
   PubMed Web of Science ®Google Scholar
• Chen H, Li Y, Wang Y, et al. An engineered bacteria-hybrid microrobot with the magnetothermal bioswitch for remotely collective perception and imaging-guided cancer treatment. ACS Nano. 2022;16(4):6118–6133. doi: 10.1021/acsnano.1c11601
   PubMed Web of Science ®Google Scholar
• Qin W, Xu W, Wang L, et al. Bacteria-elicited specific thrombosis utilizing acid-induced cytolysin a expression to enable potent tumor therapy. Adv Sci. 2022;9(15):e2105086. doi: 10.1002/advs.202105086
   Web of Science ®Google Scholar
• Precise Thermal Regulation of Engineered Bacteria Secretion for Breast Cancer Treatment In Vivo | ACS Synthetic Biology Internet [cited 2022 Dec 30]. Available from. https://pubs.acs.org/doi/abs/10.1021/acssynbio.1c00452
   Google Scholar
• Abedi MH, Yao MS, Mittelstein DR, et al. Ultrasound-controllable engineered bacteria for cancer immunotherapy. Nat Commun. 2022;13(1):1585. doi: 10.1038/s41467-022-29065-2
   PubMed Web of Science ®Google Scholar
• Harimoto T, Hahn J, Chen Y-Y, et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol. 2022;40(8):1259–1269. doi: 10.1038/s41587-022-01244-y
   PubMedGoogle Scholar
• He L, Yang H, Liu F, et al. Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth. Oncotarget. 2017;8(49):85772–85782. doi: 10.18632/oncotarget.20486
   PubMedGoogle Scholar
• He L, Yang H, Tang J, et al. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng. 2019;13(1):58. doi: 10.1186/s13036-019-0189-9
   PubMedGoogle Scholar
• Cooper RM, Wright JA, Ng JQ, et al. Engineered bacteria detect tumor DNA. Synthetic Biology. 2021; doi: 10.1101/2021.09.10.459858
   Google Scholar
• Zhang Y, Xue X, Fang M, et al. Upconversion optogenetic engineered bacteria system for time-resolved imaging diagnosis and light-controlled cancer therapy. ACS Appl Mater Interfaces. 2022;14(41):46351–46361. doi: 10.1021/acsami.2c14633
   PubMedGoogle Scholar
• Selvanesan BC, Chandra D, Quispe-Tintaya W, et al. Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice. Sci, Trans Med. 2022;14(637):eabc1600. doi: 10.1126/scitranslmed.abc1600
   PubMed Web of Science ®Google Scholar
• Vincent RL, Gurbatri CR, Redenti A, et al. Probiotic-guided CAR-T cells for universal solid tumor targeting. 2021; 2021.10.10.463366.
   Google Scholar
• Savage TM, Vincent RL, Rae SS, et al. Engineered bacteria recruit and orchestrate anti-tumor immunity. 2022; 2022.06.16.496462.
   Google Scholar
• Leventhal DS, Sokolovska A, Li N, et al. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nat Commun. 2020;11(1):2739. doi: 10.1038/s41467-020-16602-0
   PubMed Web of Science ®Google Scholar
• Chowdhury S, Castro S, Coker C, et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat Med. 2019;25(7):1057–1063. doi: 10.1038/s41591-019-0498-z
   PubMed Web of Science ®Google Scholar
• Ho CL, Tan HQ, Chua KJ, et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomed Eng. 2018;2(1):27–37. doi: 10.1038/s41551-017-0181-y
   PubMed Web of Science ®Google Scholar
• Gao T, Chen T, Feng C, et al. Design and fabrication of flexible DNA polymer cocoons to encapsulate live cells. Nat Commun. 2019;10(1):1–10. doi: 10.1038/s41467-019-10845-2
   PubMedGoogle Scholar
• Mela I, Vallejo‐Ramirez PP, Makarchuk S, et al. DNA nanostructures for targeted antimicrobial delivery. Angew Chem Int Ed Engl. 2020;59(31):12698–12702. doi: 10.1002/anie.202002740
   PubMed Web of Science ®Google Scholar
• Lahav-Mankovski N, Prasad PK, Oppenheimer-Low N, et al. Decorating bacteria with self-assembled synthetic receptors. Nat Commun. 2020;11(1):1299. doi: 10.1038/s41467-020-14336-7
   PubMed Web of Science ®Google Scholar
• Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model - Moreno - 2020 - Advanced Materials Interfaces - Wiley Online Library Internet. [cited 2022 Dec 30]. Available from. https://onlinelibrary.wiley.com/doi/abs/10.1002/admi.201901942
   Google Scholar
• Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhimurium VNP20009 in anti-PD1 therapy against melanoma - ScienceDirect [Internet]. [cited 2022 Dec 30]. Available from: https://www.sciencedirect.com/science/article/pii/S221138352200212X
   Google Scholar
• Aldaye FA, Palmer AL, Sleiman HF. Assembling Materials with DNA as the Guide. Science. 2008;321(5897):1795–1799. doi: 10.1126/science.1154533
   PubMed Web of Science ®Google Scholar
• McCarthy EF. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J. 2006;26:154–158.
   PubMedGoogle Scholar
• Zheng JH, Nguyen VH, Jiang S-N, et al. Two-step enhanced cancer immunotherapy with engineered salmonella typhimurium secreting heterologous flagellin. Sci, trans med. 2017;9(376):eaak9537. doi: 10.1126/scitranslmed.aak9537
   PubMed Web of Science ®Google Scholar
• Gurbatri CR, Lia I, Vincent R, et al. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci Transl Med. 2020;12(530):eaax0876. doi: 10.1126/scitranslmed.aax0876
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discovery. 2022;12(1):31–46. doi: 10.1158/2159-8290.CD-21-1059
   PubMed Web of Science ®Google Scholar
• Wei C, Xun AY, Wei XX, et al. Bifidobacteria expressing tumstatin protein for antitumor therapy in tumor-bearing mice. Technol Cancer Res Treat. 2016;15(3):498–508. doi: 10.1177/1533034615581977
   PubMed Web of Science ®Google Scholar
• Wood LM, Pan Z-K, Guirnalda P, et al. Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. Cancer Immunol Immunother. 2011;60(7):931–942. doi: 10.1007/s00262-011-1002-x
   PubMed Web of Science ®Google Scholar
• Liang K, Liu Q, Li P, et al. Endostatin gene therapy delivered by attenuated salmonella typhimurium in murine tumor models. Cancer Gene Ther. 2018;25(7–8):167–183. doi: 10.1038/s41417-018-0021-6
   PubMed Web of Science ®Google Scholar
• Niethammer AG, Xiang R, Becker JC, et al. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med. 2002;8(12):1369–1375. doi: 10.1038/nm1202-794
   PubMed Web of Science ®Google Scholar
• King I, Bermudes D, Lin S, et al. Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum Gene Ther. 2002;13(10):1225–1233. doi: 10.1089/104303402320139005
   PubMed Web of Science ®Google Scholar
• Yin X, Yu B, Tang Z, et al. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer. Cancer Gene Ther. 2013;20(2):77–81. doi: 10.1038/cgt.2012.86
   PubMed Web of Science ®Google Scholar
• T J, P O, D L, et al. Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer. 2006;95(9):1212–1219. doi: 10.1038/sj.bjc.6603367
   PubMed Web of Science ®Google Scholar
• Forbes NS. Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer. 2010;10(11):785–794. doi: 10.1038/nrc2934
   PubMed Web of Science ®Google Scholar
• Chandra D, Selvanesan BC, Yuan Z, et al. 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect. Oncotarget. 2017;8(13):20729–20740. doi: 10.18632/oncotarget.15117
   PubMed Web of Science ®Google Scholar
• Drees JJ, Mertensotto MJ, Augustin LB, et al. Vasculature disruption enhances bacterial targeting of autochthonous tumors. J Cancer. 2015;6(9):843–848. doi: 10.7150/jca.12491
   PubMed Web of Science ®Google Scholar
• Low KB, Ittensohn M, Le T, et al. Lipid a mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo. Nat Biotechnol. 1999;17(1):37–41. doi: 10.1038/5205
   PubMed Web of Science ®Google Scholar
• Hoffman RM. Tumor-seeking Salmonella amino acid auxotrophs. Curr Opin Biotechnol. 2011;22(6):917–923. doi: 10.1016/j.copbio.2011.03.009
   PubMed Web of Science ®Google Scholar
• Din MO, Danino T, Prindle A, et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016;536(7614):81–85. doi: 10.1038/nature18930
   PubMed Web of Science ®Google Scholar
• Wang X, Cao Z, Zhang M, et al. Bioinspired oral delivery of gut microbiota by self-coating with biofilms. Sci Adv. 2020;6(26):eabb1952. doi: 10.1126/sciadv.abb1952
   PubMed Web of Science ®Google Scholar
• Sedighi M, Zahedi Bialvaei A, Hamblin MR, et al. Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. Cancer Med. 2019;8(6):3167–3181. doi: 10.1002/cam4.2148
   PubMed Web of Science ®Google Scholar
• Platt J, Sodi S, Kelley M, et al. Antitumour effects of genetically engineered Salmonella in combination with radiation. Eur J Cancer. 2000;36(18):2397–2402. doi: 10.1016/S0959-8049(00)00336-1
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Dang LH, Abrams R, et al. Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria. Proc Natl Acad Sci U S A. 2003;100(25):15083–15088. doi: 10.1073/pnas.2036598100
   PubMed Web of Science ®Google Scholar
• Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer. 2007;97(8):1028–1034. doi: 10.1038/sj.bjc.6603990
   PubMed Web of Science ®Google Scholar
• El-Atti S A, Wasicek K, Mark S, et al. Use of probiotics in the management of chemotherapy-induced diarrhea: a case study. JPEN J Parenter Enteral Nutr. 2009;33(5):569–570. doi: 10.1177/0148607109332004
   PubMed Web of Science ®Google Scholar
• Sharma A, Rath GK, Chaudhary SP, et al. Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: a randomized double-blind placebo-controlled study. Eur J Cancer. 2012;48(6):875–881. doi: 10.1016/j.ejca.2011.06.010
   PubMed Web of Science ®Google Scholar
• Magariyama Y, Sugiyama S, Muramoto K, et al. Very fast flagellar rotation. Nature. 1994;371(6500):752. doi: 10.1038/371752b0
   PubMed Web of Science ®Google Scholar
• Shunmugam R, Renukadevi Balusamy S, Kumar V, et al. Biosynthesis of gold nanoparticles using marine microbe (Vibrio alginolyticus) and its anticancer and antioxidant analysis. J King Saud Univ Sci. 2021;33(1):101260. doi: 10.1016/j.jksus.2020.101260
   Web of Science ®Google Scholar
• Singh AV, Hosseinidoust Z, Park B-W, et al. Microemulsion-based soft bacteria-driven microswimmers for active cargo delivery. ACS Nano. 2017;11(10):9759–9769. doi: 10.1021/acsnano.7b02082
   PubMed Web of Science ®Google Scholar
• Toso JF, Gill VJ, Hwu P, et al. Phase I study of the intravenous administration of attenuated salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20(1):142–152. doi: 10.1200/JCO.2002.20.1.142
   PubMed Web of Science ®Google Scholar
• Fu S, Zhang R, Gao Y, et al. Programming the lifestyles of engineered bacteria for cancer therapy. Natl Sci Rev. 2023;10(5):nwad031. doi: 10.1093/nsr/nwad031
   PubMed Web of Science ®Google Scholar
• Pan H, Li L, Pang G, et al. Engineered NIR light-responsive bacteria as anti-tumor agent for targeted and precise cancer therapy. Chem Eng J. 2021;426:130842. doi: 10.1016/j.cej.2021.130842
   Web of Science ®Google Scholar